Bengaluru: Biocon Biologics Limited is proud to commemorate its first anniversary as a fully integrated, global biosimilars company dedicated to expanding access to high-quality affordable biologic medicines for patients worldwide. This marks the one-year milestone of Biocon Biologics’ emergence as a global enterprise operating in over 120 countries, supported by a diverse, multicultural workforce spanning more than 30 nationalities. With a robust commercial presence in key Advanced and Emerging Markets, Biocon Biologics has moved closer to patients who rely on its high-quality biosimilars to manage their debilitating conditions. By ensuring business continuity throughout this complex transition, Biocon Biologics has built trust with patients, physicians, and payors across geographies and credibility as a reliable partner. Shreehas Tambe, CEO & Managing Director, Biocon Biologics Limited, said: “I am proud and excited to celebrate Biocon Biologics’ first-year anniversary as a truly multi-national, multicultural global enterprise. We have successfully transformed the organization from a twocountry operation focused on Development and Manufacturing, to a fully integrated company with a strong Commercial engine bringing us closer to patients in over 120 countries. Having achieved several milestones and embraced new opportunities, we have laid a strong foundation for accelerated business growth that will unlock value for the company and all our stakeholders.”
